Literature DB >> 9603959

Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase.

T Ruscetti1, B E Lehnert, J Halbrook, H Le Trong, M F Hoekstra, D J Chen, S R Peterson.   

Abstract

The DNA-dependent protein kinase (DNA-PK) is a heterotrimeric enzyme that binds to double-stranded DNA and is required for the rejoining of double-stranded DNA breaks in mammalian cells. It has been proposed that DNA-PK functions in this DNA repair pathway by binding to the ends of broken DNA molecules and phosphorylating proteins that bind to the damaged DNA ends. Another enzyme that binds to DNA strand breaks and may also function in the cellular response to DNA damage is the poly(ADP-ribose) polymerase (PARP). Here, we show that PARP can be phosphorylated by purified DNA-PK, and the catalytic subunit of DNA-PK is ADP-ribosylated by PARP. The protein kinase activity of DNA-PK can be stimulated by PARP in the presence of NAD+ in a reaction that is blocked by the PARP inhibitor 1, 5-dihydroxyisoquinoline. The stimulation of DNA-PK by PARP-mediated protein ADP-ribosylation occurs independent of the Ku70/80 complex. Taken together, these results show that PARP can modify the activity of DNA-PK in vitro and suggest that these enzymes may function coordinately in vivo in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603959     DOI: 10.1074/jbc.273.23.14461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.

Authors:  F J Oliver; J Menissier-de Murcia; G de Murcia
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Hongping Yu; Hongxia Ma; Ming Yin; Qingyi Wei
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

4.  Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling.

Authors:  Mathew Sajish; Quansheng Zhou; Shuji Kishi; Delgado M Valdez; Mili Kapoor; Min Guo; Sunhee Lee; Sunghoon Kim; Xiang-Lei Yang; Paul Schimmel
Journal:  Nat Chem Biol       Date:  2012-04-15       Impact factor: 15.040

Review 5.  DNA transcription and repair: a confluence.

Authors:  Robb E Moses; Bert W O'Malley
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

6.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

7.  PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.

Authors:  I Rybanska; O Ishaq; J Chou; M Prakash; J Bakhsheshian; D L Huso; S Franco
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

8.  Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.

Authors:  L Ko; G R Cardona; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

9.  DNA-PK-dependent binding of DNA ends to plasmids containing nuclear matrix attachment region DNA sequences: evidence for assembly of a repair complex.

Authors:  Stanley K Mauldin; Robert C Getts; Wenjing Liu; Thomas D Stamato
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

10.  Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein.

Authors:  Cayetano von Kobbe; Jeanine A Harrigan; Valérie Schreiber; Patrick Stiegler; Jason Piotrowski; Lale Dawut; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2004-08-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.